Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Restructuring Costs (2016)

Lipocine's Restructuring Costs history spans 3 years, with the latest figure at $385233.0 for Q3 2016.

  • For Q3 2016, Restructuring Costs changed N/A year-over-year to $385233.0; the TTM value through Dec 2021 reached $385233.0, changed N/A, while the annual FY2021 figure was $4.0 million, N/A changed from the prior year.
  • Restructuring Costs reached $385233.0 in Q3 2016 per LPCN's latest filing, up from $773.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $385233.0 in Q3 2016 to a low of $48.0 in Q1 2013.
  • Average Restructuring Costs over 3 years is $55372.1, with a median of $403.0 recorded in 2012.
  • The largest YoY upside for Restructuring Costs was 91.81% in 2013 against a maximum downside of 87.1% in 2013.
  • A 3-year view of Restructuring Costs shows it stood at $695.0 in 2012, then rose by 11.22% to $773.0 in 2013, then surged by 49736.09% to $385233.0 in 2016.
  • Per Business Quant, the three most recent readings for LPCN's Restructuring Costs are $385233.0 (Q3 2016), $773.0 (Q2 2013), and $48.0 (Q1 2013).